Immunosuppressive Drugs Committee

|
Chair
Mercé Brunet Barcelona, Spain
|
Contact Us Scientific Committees Immunosuppressive Drugs Committee
|
 |
Vice-Chair
Stein Bergan Oslo, Norway
|
Background & Purpose of the Committee
- To provide evidence-based recommendations for TDM of immunosuppressive agents;
- To promote the knowledge and understanding of immunosuppressive drug analysis and interpretation of results;
- To enhance communication between scientists and physicians of all disciplines involved in TDM of immunosuppressive drugs; and
- To encourage the effective application of TDM in transplant medicine, with the aim of optimizing clinical drug use and maximizing the clinical and economic benefits.
Committee Initiatives for 2016/2017
- Preparation of a review article on Generic Immunosuppressive Drugs and TDM
Project coordination: Tomasz Pawinski, Pawel Kunicki
- Formation of a project group “Standardization of Immunosuppressive Drug Measurement Services” (in partnership with the IFCC).
Project coordination: Christoph Seeger, Maria Shipkova, Uwe Christians and Loralie Langman
- Preparation of an updated tacrolimus consensus document with the organization of a consensus meeting
Project coordination: Dennis Hesselink, Teun van Gelder, Pierre Marquet
- Preparation of standardized LC-MS methods for TDM of biodrugs
Project coordination: Pierre Marquet
- Submission of materials for the educational area of the IATDMCT website
Project coordination: Mercè Brunet, Dennis Hesselink, Maria Shipkova
- Committee representation at scientific meetings and congresses
Project coordination: All
- Scheduled:
- 4th EFLM-UEMS congress, Warsaw, Poland, Sep 2016 (Wieland, Marquet, Kunicki, Hesselink)
- 15th IATDMCT Congress, Kyoto, Japan, 2017
Committee Initiatives Completed in 2014/2015
- Organization of a Consensus Meeting and writing of a Consensus Document on TDM of Everolimus (September 11-12, 2014, Stuttgart, Germany)
Project coordination: Maria Shipkova, David Holt
- Writing of a review article for Therapeutic Drug Monitoring on "The need for and opportunities to perform TDM for Belatacept"
Project coordination: Dennis Hesselink, Teun van Gelder, Stein Bergan.
- Coordination of a Special Issue on Biomarkers in Transplantation and organization of the IVth Symposium on Biomarkers of Immunosuppression and Clinical Outcome in Transplantation: New Approaches on TDM of Immunosuppressive Drugs (Barcelona, December 2014).
Project coordination: Mercè Brunet
- Submission of materials for the educational area of the IATDMCT website
Project coordination: Dennis Hesselink, Maria Shipkova, Mercè Brunet
- Committee representation at scientific meetings and congresses
Project coordination: All
- IATDMCT regional meeting, Sibiu, Romania, June 6-7, 2014
- IATDMCT regional meeting, Prague, Czech Republic, August 28-30, 2014
- Symposium at the EFLM meeting, UK, Liverpool, October 7-10, 2014
- 14th IATDMCT Congress, The Netherlands, Rotterdam, October 11-15, 2015
Additional Committee Resources
Members must be logged in to access the resources below: